Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.02 CAD | -3.81% | -3.81% | -25.19% |
17/04 | NervGen Reports FY 2023 Net Loss of $0.38 Per Share, Provides Operations Update | MT |
17/04 | NervGen Pharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.19% | 103M | |
+21.74% | 46.4B | |
-0.97% | 41.75B | |
+48.09% | 41.37B | |
-3.52% | 29.71B | |
+11.12% | 26.01B | |
-19.37% | 19.52B | |
+31.18% | 12.43B | |
+0.39% | 12.18B | |
-0.04% | 12.13B |
- Stock Market
- Equities
- NGEN Stock
- News NervGen Pharma Corp.
- NervGen Pharma Up 3% after Reporting Completion of Non-Brokered Private Placement